Is 5-ASA Still the Treatment of Choice for Ulcerative Colitis?

By  

Current Drug Targets, Vol. 12, Iss. 10, 2011-09 ,pp. : 1396-1405

Bentham Science Publishers

Access to resources Recommend Favorite

Characterization of the Ascending Colon Fluids in Ulcerative Colitis

By Vertzoni Maria   Goumas Konstantinos   Söderlind Erik   Abrahamsson Bertil   Dressman Jennifer   Poulou Androniki   Reppas Christos  

Pharmaceutical Research, Vol. 27, Iss. 8, 2010-08 ,pp. : 1620-1626

Springer Publishing Company

Access to resources Recommend Favorite

Investigating Drug Repositioning Approach to Design Novel Prodrugs for Colon-specific Release of Fexofenadine for Ulcerative Colitis

By  

Current Drug Delivery, Vol. 14, Iss. 4, 2017-07 ,pp. : 543-554

Bentham Science Publishers

Access to resources Recommend Favorite

Preparation of budesonide–dextran conjugates using glutarate spacer as a colon-targeted drug delivery system: in vitro/in vivo evaluation in induced ulcerative colitis

By Varshosaz Jaleh   Emami Jaber   Ahmadi Fatemeh   Tavakoli Naser   Minaiyan Mohsen   Fassihi Afshin   Mahzouni Parvin   Dorkoosh Farid  

Journal of Drug Targeting, Vol. 19, Iss. 2, 2011-02 ,pp. : 140-153

Informa Healthcare

Access to resources Recommend Favorite

Preparation and characterization of nanocapsules for colon-targeted drug delivery system

By Kshirsagar Sanjay J.   Bhalekar Mangesh R.   Patel Jiten N.   Mohapatra Santosh K.   Shewale Nitin S.  

Pharmaceutical Development and Technology, Vol. 17, Iss. 5, 2012-10 ,pp. : 607-613

Informa Healthcare

Access to resources Recommend Favorite